drugset / Trial / NCT03613662

A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

NCT03613662

NaSingle-groupOpen-labelTreatment

Summary

This is an open-label, single-arm, repeat dose study to characterize the pharmacodynamics and safety/tolerability of SP-102 administered by epidural injection.

Timeline

Start
2018-07-13
Primary completion
2019-03-15
Completion
2019-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject SP-102 Unknown 10 mg Other

Indications